Vaccine hopes boosted by data from Novavax and J&J, but fears over new variants remain
January 29, 2021 at 11:00 AM EST
The global case tally for the coronavirus-borne illness COVID-19 was headed toward 102 million on Friday, as health experts were digesting the latest vaccine updates from Novavax Inc. and Johnson & Johnson amid hopes they will soon win emergency authorization and bolster supplies.
